Volume 7; Issue 10

Main
The Lancet Oncology
Volume 7; Issue 10

The Lancet Oncology

Volume 7; Issue 10

1

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E Kun, Thomas E Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J Krasin, Maryam Fouladi, Alberto Broniscer, Robert Kra

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 160 KB

english, 2006

2

4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index

François Blanchon, Michel Grivaux, Bernard Asselain, François-Xavier Lebas, Jean-Pierre Orlando, Jacques Piquet, Mahmoud Zureik

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 142 KB

english, 2006

3

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study

Walter A Rocca, Brandon R Grossardt, Mariza de Andrade, George D Malkasian, L Joseph Melton III

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 182 KB

english, 2006

4

Reinvention

The Lancet Oncology

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

5

Keynote comment: Radiotherapy in the age of molecular oncology

Michael Baumann

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 68 KB

english, 2006

6

High-dose chemotherapy in children with newly-diagnosed medulloblastoma

Jacques Grill, Christelle Dufour, Chantal Kalifa

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 98 KB

english, 2006

7

A better crystal ball to predict lung-cancer survival?

Amir Onn, Burton F Dickey

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 45 KB

english, 2006

8

Molecular imaging in diagnosis of neuroendocrine tumours

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

9

Risks and benefits of chloroquine use in anticancer strategies

Andrea Savarino, Mothanje B Lucia, Flavio Giordano, Roberto Cauda

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 75 KB

english, 2006

10

Preimplantation genetic diagnosis for cancer

Martinus F Niermeijer, Guido de Wert, Wybo Dondorp

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 81 KB

english, 2006

11

Is a radiotherapy boost truly beneficial?

Alison Stillie, Ian Kunkler, Gill Kerr, Helen Westenberg, Jeremy Thomas, Mike Dixon

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 81 KB

english, 2006

12

Is a radiotherapy boost truly beneficial? – Author's reply

Guenther Gruber

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

13

Errata

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

14

Errata

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

15

Errata

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

16

Speeding up cancer-drug development

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

17

New test better than immunohistochemistry?

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

18

Topotecan adds no benefit in advanced ovarian cancer

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

19

Finasteride: not guilty after all?

Tabitha M Powledge

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

20

GRP78 as potential predictor of chemoresistance

Sharan Prakash Sharma

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

21

No benefit of OSI-7904L for gastro-oesophageal cancer

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

22

Survivors of childhood cancer and suicide

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

23

Added dimensions to lung-cancer treatment

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

24

Erlotinib improves quality of life

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

25

Imatinib helps elderly patients with leukaemia

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

26

Breast reconstruction compromises radiotherapy planning

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

27

TNFα antagonist not associated with increased cancer risk

Claire Tilstone

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

28

Treatment success against stubborn lymphoid cancers

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 60 KB

english, 2006

29

New uniform response criteria for multiple myeloma

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

30

Brain-cancer link with lead exposure in workplace

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

31

News in brief

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

32

Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK

David Barnett, Andrew Stevens, Carole Longson

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 89 KB

english, 2006

33

One for sorrow, two for joy, and three for hope

Claire Tilstone

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

34

Global cost of cancer

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

35

Online cancer-risk assessment—is it really that easy?

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 80 KB

english, 2006

36

Schlafer

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

37

Pelvic exenteration for gynaecological tumours: achievements and unanswered questions

Michael Höckel, Nadja Dornhöfer

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 346 KB

english, 2006

38

Image-guided radiotherapy: rationale, benefits, and limitations

Laura A Dawson, Michael B Sharpe

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 520 KB

english, 2006

39

Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer

Lester Kwock, J Keith Smith, Mauricio Castillo, Matthew G Ewend, Frances Collichio, David E Morris, Thomas W Bouldin, Sharon Cush

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 459 KB

english, 2006

40

Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response

Robin L Jones, Ian E Smith

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 112 KB

english, 2006

41

Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient

Jan J Weenink, Johannes O Groeneveld, Carola WH de Fijter

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 99 KB

english, 2006

42

Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine

Matteo Landriscina, Sergio Modoni, Annarita Fabiano, Alberto Fersini, Carlo Barone, Antonio Ambrosi, Mauro Cignarelli

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 615 KB

english, 2006

43

Phyllodes breast tumour showing invasive squamous-cell carcinoma with invasive ductal, clear-cell, secretory, and squamous components

Michael J Ramdass, Shiva Dindyal

Journal:

The Lancet Oncology

Year:

2006

Language:

english

File:

PDF, 160 KB

english, 2006